Demand grows for secure and smarter packs

Published: 19-Feb-2015 Featured companies: Almac Group
Packaging Regulatory

As products become more complex and niche, packaging formats need to be smarter and equipment more flexible. Susan Birks reports

You need to be a subscriber to read this article.
Click here to find out more.

As the market sees the introduction of more generics, biologics and personalised medicines, packaging suppliers are having to adapt to providing more niche and complex packaging concepts and filling equipment. In some respects this is driving growth. A recent report by Life Science Industry Research on pharmaceutical product containers (bottles, vials, blister packs, etc.), for example, forecasts that this global packaging market will grow at a CAGR of 6.7% from 2013 to 2018, to reach a value of US$78.79bn.1 The report predicts market growth will be driven by the growing generics market and increased drug delivery innovation. Emerging geographies in Asia-Pacific, such as India and China, are expected to register maximum growth, due to increasing generic and contract manufacturing activities.

As most of the recent advances have been in biological therapies, which need to be injected, the fastest growth is likely to come from pre-fillable syringes and parenteral vials. Other areas of growth are expected to come from labels and accessories, blister packs and temperature-controlled packaging for medicines.

Not yet a Subscriber?

This is a small extract of the full article which is available ONLY to premium content subscribers. Click below to get premium content on Manufacturing Chemist.

Subscribe now Already a subscriber? Sign in here.

Featured companies

The Almac Group is an established contract development and manufacturing organisation which provides an extensive range of integrated services to the pharmaceutical and biotech...
  • Companies:
  • Hapa AG
  • SICK AG
  • Videojet Technologies
  • West Pharmaceutical Services
  • Global Factories Group
See more

You may also like

Manufacturing

Almac’s Charnwood facility receives FDA approval for oral dose development and manufacturing

Read more
The facility, which focuses on the manufacture of high potency oral dosage forms, has been approved for use by the FDA

Trending Articles

  1. You need to be a subscriber to read this article.
    Click here to find out more.
    Merck jumps on the GLP-1 therapeutic bandwagon by licensing Hansoh Pharma's HS-10535 Merck will be responsible for the development, manufacture and commercialisation of the investigational preclinical oral GLP-1 receptor agonist
  2. You need to be a subscriber to read this article.
    Click here to find out more.
    Why quality control should be intimately combined with sterile product development, manufacturing and the overall product supply chain With sponsor companies increasingly needing to create and launch differentiated, stable, usable and safe injectable treatments for patients, experts at ten23 health are keen to promote the importance of integrating development and/or manufacturing with quality control services
  3. Primary packaging container considerations for GLP-1-based drugs This article reviews trends related to GLP-1-type pharmaceuticals and discusses considerations for fill-and-finish and primary packaging containers
  4. Highly potent APIs: Hazards in classification and handling This variability and subjective nature of classification means that the OEL is best considered as a tool for site risk management teams
  5. The right validation model: practical considerations and applications It is widely accepted that validation in the life sciences industry follows a lifecycle model (1,2). What is not always clear is the specific model — or models — to follow and how to navigate through them in the real world. Hurdles to overcome include the specific deliverables that make up that model and how they change during the various interactions along the validation journey

Relevant companies

See more

Upcoming event

EMPQ Essentials and Real-World Strategies for Successful Cleanroom Qualifications

16 January 2025 | Virtual See all

You may also like

Manufacturing

Almac’s Charnwood facility receives FDA approval for oral dose development and manufacturing

The facility, which focuses on the manufacture of high potency oral dosage forms, has been approved for use by the FDA
Manufacturing

Almac completes “outstanding” grade by the KTP

The Innovate UK-funded KTP aimed to embed flow technologies to ensure long term security of supply for key raw materials through development
Manufacturing

Almac Sciences Ireland secures HPRA certification

This additional certification enables Almac to perform biologics testing for the determination of product quality attributes
Regulatory

Almac receives product approval by MHRA and Health Canada

The company’s site provides a range of solutions for blister packs, stickpacks, and kitting
Packaging

Enhancing clinical trial supply with JTM: part I

In a constantly changing world, the pharmaceutical industry is having to adopt its practices to serve the needs of a rapidly growing and ageing population and develop innovative personalised medicines. Almac has responded to these demands with a Just-in-Time Manufacturing solution that fulfils the requirements of a high value, time sensitive clinical supply chain. Dr Kevin Robinson spoke to Natalie Balanovsky, Just-in-Time Manufacturing Solutions Manager, and Mark Rohlfing, Vice President of Operations, to find out more
Regulatory

Almac welcomes confirmation that Northern Ireland will remain aligned with the EU post-Brexit

Move offers Almac clients unique, unfettered and flexible access to both the UK and European markets
Regulatory

Almac Group supports two COVID-19 clinical studies in sub-Saharan Africa

Grant awarded from the COVID-19 Therapeutics Accelerator, an Initiative by the Bill & Melinda Gates Foundation, Wellcome and Mastercard
Subscribe now